Skip to main content

Find Clinical Trials

Home
Conditions
Alopecia universalis

Clinical trial condition

Alopecia universalis

Explore clinical trials studying Alopecia universalis. Study availability and eligibility vary by location and protocol.

24 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Alopecia universalis trial results

Completed

Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata

NCT03800979

Conditions: Alopecia, Alopecia Areata, Alopecia universalis, +4 more
Locations: Institute of Dermatology Bangkok, Thailand

View Trial Details

Completed

PF-06651600 for the Treatment of Alopecia Areata

NCT03732807

Conditions: Alopecia, Alopecia Areata, Alopecia universalis, +6 more
Locations: The University of Alabama at Birmingham Hospital Outreach Lab Birmingham, Alabama, United States

The University of Alabama at Birmingham, Department of Dermatology Birmingham, Alabama, United States

The University of Alabama at Birmingham, Department of Dermatology Birmingham, Alabama, United States

Mosaic Dermatology Beverly Hills, California, United States

View all 155 locations

View Trial Details

Completed

A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for Alopecia

NCT04205214

Conditions: Alopecia, Alopecia Areata, Alopecia universalis, +6 more
Locations: Royal Free Hospital London, United Kingdom

View Trial Details

Completed

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

NCT03315689

Conditions: Alopecia Totalis (AT), Alopecia Universalis (AU), Alopecia universalis
Locations: Aclaris Investigational Site New York, United States

Aclaris Investigational Site New York, United States

View Trial Details

Completed

A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata

NCT02684097

Conditions: Alopecia, Alopecia Areata, Alopecia universalis, +6 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata

NCT03551821

Conditions: Alopecia, Alopecia Areata, Alopecia Totalis, +6 more
Locations: Aclaris Investigator Site Boynton Beach, Florida, United States

View Trial Details

Completed

Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

NCT02812342

Conditions: Alopecia, Alopecia Areata, Alopecia Totalis, +8 more
Locations: Yale-New Haven Hospital New Haven, Connecticut, United States

View Trial Details

Completed

Tofacitinib for the Treatment of Alopecia Areata and Its Variants

NCT02312882

Conditions: Alopecia, Alopecia Areata, Alopecia Totalis, +6 more
Locations: Stanford University Stanford, California, United States

View Trial Details

Completed

Tofacitnib for the Treatment of Alopecia Areata and Variants

NCT02197455

Conditions: Alopecia, Alopecia Areata, Alopecia Areata (AA), +7 more
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Completed

Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata

NCT00063076

Conditions: Alopecia, Alopecia Areata, Alopecia universalis, +4 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details